Live feed19:56:16·1020dSECFilingvia QuantisnowCumberland Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.CPIX· Cumberland Pharmaceuticals Inc.Health CareOriginal source